India · Delayed Price · Currency is INR SpringWorks Therapeutics Statistics
Total Valuation
BOM:514442 has a market cap or net worth of INR 637.81 million. The enterprise value is 271.06 million.
| Market Cap | 637.81M |
| Enterprise Value | 271.06M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:514442 has 20.15 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 20.15M |
| Shares Outstanding | 20.15M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 62.31% |
| Owned by Institutions (%) | n/a |
| Float | 5.67M |
Valuation Ratios
The trailing PE ratio is 13.83.
| PE Ratio | 13.83 |
| Forward PE | n/a |
| PS Ratio | 5.24 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.78, with an EV/FCF ratio of -4.25.
| EV / Earnings | 5.87 |
| EV / Sales | 2.23 |
| EV / EBITDA | 6.78 |
| EV / EBIT | 30.40 |
| EV / FCF | -4.25 |
Financial Position
The company has a current ratio of 12.49, with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.49 |
| Quick Ratio | 10.48 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.93 |
| Debt / FCF | -0.58 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.85% and return on invested capital (ROIC) is 0.46%.
| Return on Equity (ROE) | 3.85% |
| Return on Assets (ROA) | 0.42% |
| Return on Invested Capital (ROIC) | 0.46% |
| Return on Capital Employed (ROCE) | 0.68% |
| Revenue Per Employee | 9.36M |
| Profits Per Employee | 3.55M |
| Employee Count | 13 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.61 |
Taxes
In the past 12 months, BOM:514442 has paid 11.30 million in taxes.
| Income Tax | 11.30M |
| Effective Tax Rate | 19.67% |
Stock Price Statistics
The stock price has decreased by -7.70% in the last 52 weeks. The beta is 0.75, so BOM:514442's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -7.70% |
| 50-Day Moving Average | 28.77 |
| 200-Day Moving Average | 29.39 |
| Relative Strength Index (RSI) | 51.43 |
| Average Volume (20 Days) | 15,409 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:514442 had revenue of INR 121.63 million and earned 46.15 million in profits. Earnings per share was 2.29.
| Revenue | 121.63M |
| Gross Profit | 116.24M |
| Operating Income | 8.92M |
| Pretax Income | 57.45M |
| Net Income | 46.15M |
| EBITDA | 39.97M |
| EBIT | 8.92M |
| Earnings Per Share (EPS) | 2.29 |
Balance Sheet
The company has 403.78 million in cash and 37.03 million in debt, giving a net cash position of 366.76 million or 18.21 per share.
| Cash & Cash Equivalents | 403.78M |
| Total Debt | 37.03M |
| Net Cash | 366.76M |
| Net Cash Per Share | 18.21 |
| Equity (Book Value) | 1.22B |
| Book Value Per Share | 61.06 |
| Working Capital | 483.69M |
Cash Flow
In the last 12 months, operating cash flow was -57.37 million and capital expenditures -6.37 million, giving a free cash flow of -63.74 million.
| Operating Cash Flow | -57.37M |
| Capital Expenditures | -6.37M |
| Free Cash Flow | -63.74M |
| FCF Per Share | -3.16 |
Margins
Gross margin is 95.57%, with operating and profit margins of 7.33% and 37.94%.
| Gross Margin | 95.57% |
| Operating Margin | 7.33% |
| Pretax Margin | 47.23% |
| Profit Margin | 37.94% |
| EBITDA Margin | 32.86% |
| EBIT Margin | 7.33% |
| FCF Margin | n/a |
Dividends & Yields
BOM:514442 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | n/a |
| Earnings Yield | 7.23% |
| FCF Yield | -9.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |